Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
-based genome editing tools into next-generation gene therapies to treat those untreatable human genetic diseases, such as cystic fibrosis and liver cancer. To achieve this, we will engineer advanced
-
development and regeneration. Our research combines in vivo genetic models, in vitro organoid systems, advanced imaging, and high-dimensional sequencing approaches to uncover fundamental principles by which
-
proficient with microbial genetics, molecular microbiology, basic tissue culture and molecular biology techniques. Prior experience with bioinformatics (microbial sequencing and proteomics) would be
-
multi-omics (PMIDs:33558758 [Nature Genetics 2021], 33514395 [Genome Biology 2021], and 33627474 [Genome Research 2021]), electronic health records (100 million electronic patient records, PMID
-
toxicities, neuron-glia interactions, genetics and epigenetics will provide insights in identifying novel biomarkers and drug targets. Expand and improve skills: disease models based on genome-modified animals
-
of seed gene networks”. This project aims to use reverse genetics, cross-species complementation and single cell next-generation sequencing approaches to investigate how the gene networks that regulate
-
fluorescence microendoscopy Fiber photometry & optogenetics Genetically encoded molecular tools We focus on behaviors such as reward learning, fear learning and motor learning, with strong interest in primary
-
recently funded 5-year programme of antifungal drug discovery at the MRC Centre for Medical Mycology. This exciting new programme connects MRC CMM researchers with drug discovery experts and scientists from
-
; perform downstream bioinformatic analysis using appropriate tools (e.g., Seurat, Scanpy, Cell Ranger). • Analyze whole genome sequencing data sets • Collaborate with clinicians, computational biologists
-
of medicine through cutting-edge research. Leveraging multiomics, mouse genetics, hiPS cells, and electrophysiology, our lab works on molecular mechanism of cardiometabolic oncology. The postdoctoral fellow